Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Retained Earnings (2020 - 2026)

IceCure Medical has reported Retained Earnings over the past 7 years, most recently at -$124.7 million for Q1 2026.

  • For Q1 2026, Retained Earnings changed N/A year-over-year to -$124.7 million; the TTM value through Mar 2026 reached -$124.7 million, changed N/A, while the annual FY2025 figure was -$120.4 million, 14.29% down from the prior year.
  • Retained Earnings was -$124.7 million for Q1 2026 at IceCure Medical, down from -$120.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$75.4 million in Q4 2022 and bottomed at -$124.7 million in Q1 2026.
  • The 5-year median for Retained Earnings is -$105.4 million (2024), against an average of -$103.2 million.
  • Year-over-year, Retained Earnings fell 29.06% in 2022 and then fell 14.29% in 2025.
  • Over 5 years, Retained Earnings stood at -$75.4 million in 2022, then dropped by 19.43% to -$90.1 million in 2023, then dropped by 17.01% to -$105.4 million in 2024, then fell by 14.29% to -$120.4 million in 2025, then decreased by 3.55% to -$124.7 million in 2026.
  • The last three reported values for Retained Earnings were -$124.7 million (Q1 2026), -$120.4 million (Q4 2025), and -$105.4 million (Q4 2024) per Business Quant data.